Nektar Therapeutics
Organization details
- Legal name
- Nektar Therapeutics
- Former names
- Inhale Therapeutic Systems Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NKTR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000906709
- EIN
- 94-3134940
- Wikidata ID
- Q17114308
Board of directors
-
Diana Brainard · DirectorSince 2023
-
Howard W. Robin · Director · President & CEOSince 2023
-
Jeffrey Robert Ajer · DirectorSince 2023
-
Myriam Curet · DirectorSince 2023
-
R. Scott Greer · DirectorSince 2023
-
Robert Chess · DirectorSince 2023
-
Roy A. Whitfield · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
72.6%
Board connections
4 of this board's directors also sit on 6 other boards. 6 are in the same sector.
-
Inspire Medical Systems Inc. Same sectorvia Myriam Curet
-
Kalaris Therapeutics Inc. Same sectorvia Diana Brainard
-
Mobia Medical Inc. Same sectorvia Myriam Curet
-
Stereotaxis Inc. Same sectorvia Myriam Curet
-
Twist Bioscience Corporation Same sectorvia Robert Chess
-
Viridian Therapeutics Inc. Same sectorvia Jeffrey Robert Ajer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,433,286
- 16 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Jeffrey Robert Ajer Director | Grant or award | +2,000 | — | — |
| Sep 23, 2026 | Diana Brainard Director | Grant or award | +2,000 | — | — |
| Sep 23, 2026 | Robert Chess Director | Grant or award | +2,000 | — | — |
| Sep 23, 2026 | R. Scott Greer Director | Grant or award | +2,000 | — | — |
| Sep 23, 2026 | Roy A. Whitfield Director | Grant or award | +2,000 | — | — |
| Aug 18, 2026 | Howard W. Robin Director, Officer (President & CEO) | Open-market sale | −418 | $71.98 | $30,088 |
| Aug 18, 2026 | Zalevsky Jonathan Officer (Chief R&D Officer) | Open-market sale | −186 | $71.98 | $13,388 |
| Jun 30, 2026 | Zalevsky Jonathan Officer (Chief R&D Officer) | Open-market sale | −5,681 | $70.00 | $397,670 |
| Jun 17, 2026 | Howard W. Robin Director, Officer (President & CEO) | Open-market sale | −5,500 | $60.81 | $334,455 |
| Jun 17, 2026 | Howard W. Robin Director, Officer (President & CEO) | Open-market sale | −4,500 | $61.65 | $277,425 |
| Jun 16, 2026 | Howard W. Robin Director, Officer (President & CEO) | Open-market sale | −5,303 | $59.97 | $318,021 |
| Jun 16, 2026 | Howard W. Robin Director, Officer (President & CEO) | Open-market sale | −4,697 | $60.71 | $285,155 |
| Jun 15, 2026 | Zalevsky Jonathan Officer (Chief R&D Officer) | Open-market sale | −5,538 | $60.71 | $336,212 |
| May 19, 2026 | Zalevsky Jonathan Officer (Chief R&D Officer) | Open-market sale | −199 | $65.51 | $13,036 |
| May 19, 2026 | Howard W. Robin Director, Officer (President & CEO) | Open-market sale | −444 | $65.51 | $29,086 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Nektar Therapeutics
Who is the CEO of Nektar Therapeutics?
Howard W. Robin is Nektar Therapeutics's President & CEO.
How many directors are on Nektar Therapeutics's board?
Nektar Therapeutics's board has 7 directors: Diana Brainard, Howard W. Robin, Jeffrey Robert Ajer, Myriam Curet, R. Scott Greer, Robert Chess and Roy A. Whitfield.
Are Nektar Therapeutics insiders buying or selling shares?
Over the last 12 months, Nektar Therapeutics insiders made no open-market purchases and sold $2.4 million of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="nektar-therapeutics"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.